In 2010, a new histopathological classification of ANCA-associated glomerulonephritis (ANCA-GN) based on four categories (focal, crescentic, mixed, and sclerotic) was proposed to predict renal outcome. However, this classification was the source of much debate in different populations. We aimed to evaluate this classification scheme in terms of renal survival using Bayesian network meta-analysis.
We searched Pubmed, Embase, and Medline for articles published between 1 October 2010 and 9 August 2017 that assessed the predictive value of this classification. We pooled hazard ratios (HRs) for end-stage kidney disease (ESRD) among the four categories using a Bayesian random-effects model. Clinical factors that could potentially influence renal outcome among the different trials were explored by meta-regression.
Sixteen case-controlled studies, including a total of 1945 patients with 1695 endpoint events, were included. Compared with sclerotic, the HRs for ESRD were 0.45 [95% confidence interval (CI) 0.26–0.79] for crescentic, 0.34 (0.22–0.51) for mixed, and 0.24 (0.12–0.51) for focal. Pooled results showed no obvious difference between the crescentic and the mixed sub-groups (HR 1.35; 95% CI 0.90–2.0). Baseline eGFR (P = 0.002) and the ANCA serology (P = 0.029) were associated with renal survival.
The 2010 ANCA-GN classification and the extent of ANCA serology and baseline eGFR were shown to be significant predictors of renal outcome, although there was no significant prognostic difference between crescentic and mixed. The ANCA-GN classification scheme should, therefore, be optimized by combining with other established parameters, such as tubular atrophy and the proportion of normal glomeruli.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Jennette JC, Falk RJ, Hu P et al (2013) Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Ann Rev Pathol 8:139–160. https://doi.org/10.1146/annurev-pathol-011811-132453
Bajema IM, Hagen EC, Hermans J et al (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56(5):1751–1758. https://doi.org/10.1046/j.1523-1755.1999.00758.x
Hauer HA, Bajema IM, Van Houwelingen HC et al (2002) Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 62(5):1732–1742. https://doi.org/10.1046/j.1523-1755.2002.00605.x
Hauer HA, Bajema IM, van Houwelingen HC et al (2002) Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 61(1):80–89. https://doi.org/10.1046/j.1523-1755.2002.00089.x
de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17(8):2264–2274. https://doi.org/10.1681/asn.2005080870
Berden AE, Ferrario F, Hagen EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21(10):1628–1636. https://doi.org/10.1681/asn.2010050477
Bjorneklett R, Sriskandarajah S, Bostad L (2016) Prognostic value of histologic classification of ANCA-associated glomerulonephritis. Clin J Am Soc Nephrol 11(12):2159–2167. https://doi.org/10.2215/cjn.04800516
Chang DY, Wu LH, Liu G et al (2012) Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 27(6):2343–2349. https://doi.org/10.1093/ndt/gfr643
Cordova-Sanchez BM, Mejia-Vilet JM, Morales-Buenrostro LE et al (2016) Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol 35(7):1805–1816. https://doi.org/10.1007/s10067-016-3195-z
Ellis CL, Manno RL, Havill JP et al (2013) Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome. BMC Nephrol 14:210. https://doi.org/10.1186/1471-2369-14-210
Ford SL, Polkinghorne KR, Longano A et al (2014) Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis. Am J Kidney Dis 63(2):227–235. https://doi.org/10.1053/j.ajkd.2013.08.025
Hilhorst M, Wilde B, van Breda Vriesman P et al (2013) Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol 24(9):1371–1375. https://doi.org/10.1681/asn.2012090912
Iwakiri T, Fujimoto S, Kitagawa K et al (2013) Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol 14:125. https://doi.org/10.1186/1471-2369-14-125
Moroni G, Binda V, Leoni A et al (2015) Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopatological classification schema and review of the literature. Clin Exp Rheumatol. http://www.clinexprheumatol.org/abstract.asp?a=9259. Accessed 10 Sept 2017
Muso E, Endo T, Itabashi M et al (2013) Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts. Clin Exp Nephrol 17(5):659–662. https://doi.org/10.1007/s10157-012-0755-7
Naidu GS, Sharma A, Nada R et al (2014) Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome. Rheumatol Int 34(12):1721–1727. https://doi.org/10.1007/s00296-014-3041-z
Nohr E, Girard L, James M et al (2014) Validation of a histopathologic classification scheme for antineutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol 45(7):1423–1429. https://doi.org/10.1016/j.humpath.2014.02.017
Noone DG, Twilt M, Hayes WN et al (2014) The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood. Clin J Am Soc Nephrol 9(10):1684–1691. https://doi.org/10.2215/cjn.01210214
Quintana LF, Perez NS, De Sousa E et al (2014) ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 29(9):1764–1769. https://doi.org/10.1093/ndt/gfu084
Tanna A, Guarino L, Tam FW (2015) Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant 30(7):1185–1192. https://doi.org/10.1093/ndt/gfu237
Diaz-Crespo F, Villacorta J, Acevedo M et al (2016) The predictive value of kidney biopsy in renal vasculitis: a multicenter cohort study. Hum Pathol 52:119–127. https://doi.org/10.1016/j.humpath.2016.01.015
Chen YX, Xu J, Pan XX et al (2017) Histopathological classification and renal outcome in patients with antineutrophil cytoplasmic antibodies-associated renal vasculitis: a study of 186 patients and metaanalysis. J Rheumatol 44(3):304–313. https://doi.org/10.3899/jrheum.160866
Tierney JF, Stewart LA, Ghersi D et al (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16. https://doi.org/10.1186/1745-6215-8-16
Wells G, Shea B, O’Connell D et al (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Woods BS, Hawkins N, Scott DA (2010) Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial. BMC Med Res Methodol 10:54. https://doi.org/10.1186/1471-2288-10-54
Mills EJ, Thorlund K, Ioannidis JP (2013) Demystifying trial networks and network meta-analysis. BMJ 346:f2914. https://doi.org/10.1136/bmj.f2914
Brooks S, Gelman A (1998) General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. https://doi.org/10.1080/10618600.1998.10474787. https://www.researchgate.net/publication/229099827
Franssen CF, Stegeman CA, Kallenberg CG et al (2000) Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 57(6):2195–2206. https://doi.org/10.1046/j.1523-1755.2000.00080.x
Jayne DR, Gaskin G, Rasmussen N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18(7):2180–2188. https://doi.org/10.1681/asn.2007010090
Lapraik C, Watts R, Bacon P et al (2007) BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology 46(10):1615–1616. https://doi.org/10.1093/rheumatology/kem146a
Neumann I, Kain R, Regele H et al (2005) Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20(1):96–104. https://doi.org/10.1093/ndt/gfh563
Hogan SL, Nachman PH, Wilkman AS et al (1996) Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7(1):23–32
Berden AE, Jones RB, Erasmus DD et al (2012) Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol 23(2):313–321. https://doi.org/10.1681/asn.2011040330
Roberts IS, Cook HT, Troyanov S et al (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76(5):546–556. https://doi.org/10.1038/ki.2009.168
Harris AA, Falk RJ, Jennette JC (1998) Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis 32(1):179–184
Kristensen T, Gregersen JW, Krag SR, Ivarsen P (2016) The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis. Clin Exp Rheumatol 34(3 Suppl 97):S105–S110
Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21:1559–1573. https://doi.org/10.1002/sim.1187
Chalmers I (1993) The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci 703:156–165. https://www-ncbi-nlm-nih-gov.proxygsu-uga1.galileo.usg.edu/pubmed/8192293
Flossmann O, Berden A, de Groot K et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70(3):488–494. https://doi.org/10.1136/ard.2010.137778
The authors would like to thank all authors of the included studies in our meta-analysis.
Conflict of interest
The authors declare that they have no conflicts of interest.
As the study was a meta-analysis based on the existing population-based studies, we did not apply for the approval of institutional review board.
About this article
Cite this article
Huang, S., Shen, Q., Yang, R. et al. An evaluation of the 2010 histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a Bayesian network meta-analysis. Int Urol Nephrol 50, 1853–1861 (2018). https://doi.org/10.1007/s11255-018-1941-7
- ANCA-associated vasculitis
- ANCA-associated glomerulonephritis
- Renal pathology